Is the C-reactive protein-to-albumin ratio the most remarkable simple inflammatory marker showing active disease in patients with axial spondyloarthritis, psoriatic arthritis, and rheumatoid arthritis?

被引:6
|
作者
Kaplan, Huseyin [1 ]
Cengiz, Gizem [1 ]
Sas, Senem [1 ]
Eldemir, Yasemin Ozden [2 ]
机构
[1] Erciyes Univ, Fac Med, Dept Phys Med & Rehabil, Div Rheumatol, Kayseri, Turkiye
[2] Erciyes Univ, Fac Med, Dept Internal Med, Div Rheumatol, Kayseri, Turkiye
关键词
axial spondyloarthritis; disease activity; inflammation; psoriatic arthritis; rheumatoid arthritis; ANKYLOSING-SPONDYLITIS; LYMPHOCYTE RATIO; CLASSIFICATION CRITERIA; ACTIVITY SCORE-28; FIBRINOGEN RATIO; REMISSION; ASSOCIATION; ASDAS; CRP;
D O I
10.1007/s10067-023-06703-8
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective To learn which of the simple inflammation markers obtained from routine laboratory tests showed active disease best. Methods The study included 256 patients (102 patients with axial spondyloarthritis [axSpA], 54 with psoriatic arthritis [PsA], and 100 with rheumatoid arthritis [RA]). The results of the routine laboratory tests requested during the outpatient clinic visits of the patients were noted. Inflammation-related ratio/indices were then calculated from these laboratory tests. Active and inactive diseases were defined according to the disease activity scores for each disease. Logistic regression and receiver operating characteristic (ROC) analyses were performed to determine the best laboratory marker(s) showing active disease and its cutoff value for all three diseases. Results C-reactive protein to albumin ratio (CAR) was significantly higher in patients with active axSpA, PsA, and RA diseases than those with inactive diseases ( p < 0.001, p = 0.006, and p < 0.001, respectively). In the logistic regression analysis, the CAR was the most important predictor of active disease in patients with axSpA, PsA, and RA. CAR had also showed the active disease at an acceptable level in axSpA and PsA and very well in RA. The cutoff values for active disease in axSpA, PsA, and RA were 0.75, 0.92, and 0.89, respectively. Conclusion CAR may be a promising simple laboratory marker to distinguish active disease in patients with axSpA, PsA, and RA. Key Points center dot Acute phase reactants and circulating blood cells have become an important target because of the search for a disease activity marker that can be used cheaply and quickly in the daily outpatient routine. center dot One or more of these simple markers have been previously discussed in various studies with different hypotheses. center dot We aimed to determine which of the inflammation markers obtained from routine laboratory tests showed active disease and to determine a cutoff value for this/these marker(s). center dot CAR was the most important simple laboratory marker to distinguish active disease in patients with axSpA, PsA, and RA. In addition, CAR showed the active disease at an acceptable level in axSpA and PsA, and very well in RA.
引用
收藏
页码:2959 / 2969
页数:11
相关论文
共 50 条
  • [41] Comparative Disease Burden in Patients with Rheumatoid Arthritis, Psoriatic Arthritis, or Axial Spondyloarthritis: Data from Two Corrona Registries
    Philip J. Mease
    Mei Liu
    Sabrina Rebello
    Hyungjoo Kang
    Esther Yi
    Yujin Park
    Jeffrey D. Greenberg
    Rheumatology and Therapy, 2019, 6 : 529 - 542
  • [42] C-Reactive Protein-to-Albumin Ratio as Prognostic Marker for Anal Squamous Cell Carcinoma Treated With Chemoradiotherapy
    Martin, Daniel
    Roedel, Franz
    Balermpas, Panagiotis
    Winkelmann, Ria
    Fokas, Emmanouil
    Roedel, Claus
    FRONTIERS IN ONCOLOGY, 2019, 9
  • [43] C-Reactive Protein-to-Albumin Ratio Predicts Sepsis an Prognosis in Patients with Severe Burn Injury
    Yu, Yaohua
    Wu, Weiwei
    Dong, Yanyan
    Li, Jiliang
    MEDIATORS OF INFLAMMATION, 2021, 2021
  • [44] SERUM CALPROTECTIN MAY REFLECT INFLAMMATORY ACTIVITY IN PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS DESPITE NORMAL C-REACTIVE PROTEIN
    Hurnakova, J.
    Hulejova, H.
    Zavada, J.
    Komarc, M.
    Cerezo, L. Andres
    Mann, H.
    Vencovsky, J.
    Pavelka, K.
    Senolt, L.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 243 - 244
  • [45] LACK OF C-REACTIVE PROTEIN RESPONSE IN PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS: WHAT ARE THE IMMUNOLOGICAL CAUSES?
    Bradford, Claire M.
    Kidd, Lindsey
    Howard, Victoria
    Ciurtin, Coziana
    Jury, Elizabeth C.
    Jessica, Manson J.
    RHEUMATOLOGY, 2016, 55 : 90 - 90
  • [46] C-reactive protein-to-albumin ratio and six-month mortality in incident hemodialysis patients
    Sant'Ana, Mariana
    Gameiro, Joana
    Costa, Claudia
    Branco, Carolina
    da Silva, Bernardo Marques
    Peres, Nadiesda
    Cardoso, Ana
    Abrantes, Ana Mafalda
    Fonseca, Jose Agapito
    Outerelo, Cristina
    Resina, Cristina
    Lopes, Jose Antonio
    RENAL FAILURE, 2023, 45 (01)
  • [47] The role of C-reactive protein-to-albumin ratio as a prognostic biomarker in patients hospitalized for cardiorenal syndrome
    Theofilis, Panagiotis
    Vordoni, Aikaterini
    Karakasis, Paschalis
    Volis, Nikolaos
    Kampourelli, Aikaterini
    Doumani, Georgia
    Xanthopoulou, Eleni
    Kalaitzidis, Rigas G.
    CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2024, : 469 - 476
  • [48] LOCALIZATION OF C-REACTIVE PROTEIN IN SYNOVIUM OF PATIENTS WITH RHEUMATOID-ARTHRITIS
    GITLIN, JD
    GITLIN, JI
    GITLIN, D
    ARTHRITIS AND RHEUMATISM, 1977, 20 (08): : 1491 - 1499
  • [49] LOCALIZATION OF C-REACTIVE PROTEIN IN SYNOVIUM OF PATIENTS WITH RHEUMATOID-ARTHRITIS
    GITLIN, JD
    GITLIN, JI
    GITLIN, D
    PEDIATRIC RESEARCH, 1977, 11 (04) : 486 - 486
  • [50] Assessment of cardiovascular risk with C-reactive protein in rheumatoid arthritis patients
    Queiros, Rita
    Salvador, Fernando
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2022, 104 : 39 - 40